BioNTech Inc. - Biji pasar BNTX

Simbol resmi perusahaan BioNTech Pharma (BNTX)

BioNTech SE (BNTX) is minimizing risks by adapting mRNA technologies to combat autoimmune pathologies and cancer. The company is currently transforming its portfolio by implementing breakthrough standards for individualized tumor therapy. Business success relies on R&D efficiency and capital burn, which constitutes 22.96. Serving as an assessment tool, this value chart on GURU.Markets allows for tracking the impact of clinical trials and M&A deals on the issuer's capitalization.

BNTX (BioNTech) riwayat Kapitalisasi pasar saka 04.07.2022 nganti 22.10.2026

Rincian metrik komprehensif lan analitis BioNTech Pharma (BNTX)

Indikator keuangan lan pasar perusahaan BioNTech SE (BNTX):
Analisis fundamental perusahaan:BNTX (BioNTech)
Sampel barang BioNTech Pharma

Market capitalization is calculated as the product of the current share price and the total number of shares outstanding, reflecting the aggregate value of the business in real time. For BioNTech SE (BNTX), this metric measures market confidence in the potential of mRNA technologies, where future pricing power in the development of cancer treatments directly determines the market capitalization dynamics of the issuer.

Pesaing wigati

Nilai pasar argenx ARGX|ABVX: Kapitalisasi pasar|ADMA: Biji pasar|Protagonist Corp - Nilai pasar|IMVT (Immunovant, Inc.) - Biji pasar|Kapitalisasi pasar KNSA|Nilai pasar Grifols|Adaptive Biotech - Biji pasar|Kapitalisasi pasar CLDX|AUPH (Aurinia Corp) - Nilai pasar|Kapitalisasi pasar BCRX (BioCryst)|Kapitalisasi pasar veratx.com VERA|DNTH - Nilai pasar|Nilai pasar PHVS (Pharvaris NV)|AbCellera (ABCL) - Nilai pasar|Biji pasar Tourmaline|PGEN (Precigen, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar pharming.com|Biji pasar NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Nilai pasar|Kapitalisasi pasar ZBIO (Zenas Biopharma, Inc.)|Kapitalisasi pasar Immunome Bio (IMNM)|GOSS - Nilai pasar|kalvista.com (KALV) - Biji pasar|Septerna (SEPN) - Nilai pasar|Biji pasar Pieris Pharma|Biji pasar SVRA|Kapitalisasi pasar Rigel Corp|Nilai pasar AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalisasi pasar|Kapitalisasi pasar ENGN (enGene)|rapt.com (RAPT) - Nilai pasar|Aerovate - Kapitalisasi pasar|ACRS: Nilai pasar|KYTX: Kapitalisasi pasar|TLSA - Kapitalisasi pasar|Nilai pasar Cabaletta Bio|Nilai pasar Ventyx Biosciences Inc. VTYX|Nilai pasar Theratechnologies Inc (THTX)|Avalo Therapeutics Inc - Kapitalisasi pasar|Eledon Pharmaceuticals - Biji pasar|Nilai pasar AGEN (agenusbio.com)|Climb Bio - Kapitalisasi pasar|Nilai pasar zurabio.com|ATYR: Kapitalisasi pasar|Biji pasar Adagene Inc.|IMA (ImageneBio) - Kapitalisasi pasar|STTK: Nilai pasar|Biji pasar EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Nilai pasar|Nilai pasar Immunic IMUX|Kapitalisasi pasar Atara Biotherapeutics, Inc. (ATRA)|InflaRx GmbH - Kapitalisasi pasar|Nilai pasar x4pharma.com|ACET: Kapitalisasi pasar|CELU (Celularity) - Nilai pasar|Nilai pasar INmune Bio Corp|Kapitalisasi pasar BRNS (Barinthus Biotherapeutics Corp)|Biji pasar KZR (Kezar Life Sciences)|Nilai pasar SABS|Akari Therapeutics Plc - Biji pasar|ENLV: Kapitalisasi pasar|QTTB - Nilai pasar|Biji pasar GOVX|EDSA: Kapitalisasi pasar|ibioinc.com - Nilai pasar|CARM (Carisma Therapeutics Inc) - Kapitalisasi pasar|Kapitalisasi pasar XTL Biopharmaceuticals Ltd|Nilai pasar Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - Nilai pasar|Nilai pasar Aptevo Therapeutics Inc. APVO|AIM - Biji pasar|Aditxt Corp - Kapitalisasi pasar|GRI - Kapitalisasi pasar|XRTX (XORTX) - Biji pasar|Vyome Therapeutics - Nilai pasar|REVB (Revelation Biosciences) - Kapitalisasi pasar|indaptusrx.com (INDP) - Kapitalisasi pasar|Nilai pasar Scinai Immunotherapeutics Ltd. (SCNI)|Biji pasar calcimedica.com CALI|Nilai pasar Affimed N.V. AFMD|ALLK - Biji pasar|HOOK: Biji pasar|IGMS - Kapitalisasi pasar|iTeos Therapeutics, Inc. (ITOS) - Nilai pasar|Kapitalisasi pasar OCEA|TCBP (TC BioPharm (Holdings) PLC) - Kapitalisasi pasar|Nilai pasar Third Harmonic Bio Inc THRD